«BioEq» recruits for patients to participate in a
phase III clinical study in NSCLC.
Study medication: anti-PD-L monoclonal antibody.
We invite adult male and female patients. You can request any additional information by phone.
Please contact us at 8-812-945-22-32 to learn more.